Neogen (FRA:NG2) Scaled Net Operating Assets : 0.84 (As of Feb. 2024)

View and export this data going back to 1989. Start your Free Trial

What is Neogen Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Neogen's operating assets for the quarter that ended in Feb. 2024 was €4,091.8 Mil. Neogen's operating liabilities for the quarter that ended in Feb. 2024 was €506.3 Mil. Neogen's Total Assets for the quarter that ended in Nov. 2023 was €4,252.6 Mil. Therefore, Neogen's scaled net operating assets (SNOA) for the quarter that ended in Feb. 2024 was 0.84.

Neogen Scaled Net Operating Assets Historical Data

The historical data trend for Neogen's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neogen Scaled Net Operating Assets Chart

Neogen Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.63

0.56

0.52

0.63

3.70

Neogen Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.80	0.83	0.83	0.84	0.84

Competitive Comparison of Neogen's Scaled Net Operating Assets

For the Diagnostics & Research subindustry, Neogen's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neogen's Scaled Net Operating Assets Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Neogen's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Neogen's Scaled Net Operating Assets falls into.

Neogen Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Neogen's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in May. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: May. 2023 )
=	(Operating Assets (A: May. 2023 )	-	Operating Liabilities (A: May. 2023 ))	/	Total Assets (A: May. 2022 )
=	(3964.154	-	491.994)	/	939.311
=	3.70

where

	Operating Assets		(A: May. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	4190.077	-	225.923
=	3964.154

	Operating Liabilities		(A: May. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1306.598	-	814.604	-	0
=	491.994

Neogen's Scaled Net Operating Assets (SNOA) for the quarter that ended in Feb. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Feb. 2024 )
=	(Operating Assets (Q: Feb. 2024 )	-	Operating Liabilities (Q: Feb. 2024 ))	/	Total Assets (Q: Nov. 2023 )
=	(4091.82	-	506.276)	/	4252.631
=	0.84

where

	Operating Assets		(Q: Feb. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	4247.97	-	156.15
=	4091.82

	Operating Liabilities		(Q: Feb. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1331.467	-	822.854	-	2.337
=	506.276

Neogen Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Neogen's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Neogen (FRA:NG2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Neogen Corp (FRA:NG2) » Definitions » Scaled Net Operating Assets

Comparable Companies

GH SHC TWST NEO RDNT MYGN VCYT LAB OPK FLGT TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

NEOG:USA NG2:Germany

Address

620 Lesher Place, Lansing, MI, USA, 48912

Website

https://www.neogen.com

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.

Neogen (FRA:NG2) Headlines

No Headlines